⚡ Summer Research Season — Save 15% with code ATOMIX15 Free shipping on orders over $150 99%+ purity · Made in the USA · COA with every batch ⚡ Summer Research Season — Save 15% with code ATOMIX15 Free shipping on orders over $150 99%+ purity · Made in the USA · COA with every batch
Home / Atomix Research / BPC-157 (5 mg, 10 mg)
BPC-157 (5 mg, 10 mg)
Pentadecapeptide for tissue repair and angiogenesis research
CAS No.
137525-51-0
Mol. weight
~ 1419.5 g/mol
Purity
>99% HPLC
Form
White lyophilized powder
Price range: $24.99 through $49.99
In stock · Ships within 48–72 hours
Multi-vial bulk discounts — same product
Discounts apply per product line, not across your full cart.
3 vials
10% off
MOST POPULAR
5 vials
15% off
10 vials
20% off
🔒Secure checkout
⚗3rd-party tested
🚚Tracked shipping
✓Quality assured
Research use only
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a partial sequence of body protection compound found in gastric juice. It has been extensively studied in preclinical models for its regenerative and cytoprotective effects. Research suggests that BPC-157 promotes angiogenesis, accelerates wound healing, supports tendon and ligament recovery, and exhibits gastroprotective properties. Additionally, it has shown potential neuroprotective and cardioprotective activities in various experimental models, making it a widely explored peptide in tissue repair and regenerative medicine research.
Synonyms BPC-157, PL-14736, Body Protection Compound-157 Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Molecular Formula C62H98N16O22 Molecular Weight ~ 1419.5 g/mol CAS Number 137525-51-0 Appearance White lyophilized powder
Supplied as a lyophilized powder in vials (5 mg and 10 mg). For short-term storage, keep at room temperature protected from light. For long-term stability, store at –20 °C in a calm, dry environment. Upon reconstitution with sterile water or buffer, aliquot and store at –20 °C, avoiding repeated freeze–thaw cycles.
For laboratory research use only. Products are not for human consumption. Atomix Research is a chemical supplier and not a compounding pharmacy. All products are sold for research, laboratory, or analytical purposes only. You must be over 21 to purchase from this site.
Certificate of Analysis
Third-party tested · HPLC verified on every batch
LATEST
99.404%
Purity
Variant5 mg
Lot #386921
Labeled5 mg
TestedOctober 22, 2024
📄 View COA
100%
Purity
Variant10 mg
Lot #386920
Labeled10 mg
TestedOctober 22, 2024
📄 View COA
Sources & References
Peer-reviewed literature underpinning this research compound
Vasireddi N, Hahamyan H, Salata MJ, et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS Journal, 2025. PubMed ↗ Chang CH, Tsai WC, Lin MS, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology, 2011. View Study ↗ Hsieh MJ, Lee CH, Chueh HY, et al. Modulatory effects of BPC 157 on vasomotor tone and the Src-Cav-1-eNOS signaling pathway in rats. Scientific Reports, 2020. View Study ↗ He L, Feng D, Guo H, et al. Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs. Frontiers in Pharmacology, 2022. View Study ↗ Xu C, Sun L, Ren F, et al. Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds. Regulatory Toxicology and Pharmacology, 2020. PubMed ↗ Sikiric P, Seiwerth S, Rucman R, et al. Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. Current Neuropharmacology, 2016. Full Text (PMC) ↗ Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection Revisited. Gut and Liver, 2019. View Study ↗ Józwiak M, Bauer M, Kamysz W, Kleczkowska P. Multifunctionality and Possible Medical Application of the BPC 157 Peptide. Pharmaceuticals (MDPI), 2025. View Study ↗ PCO-02 – Safety and Pharmacokinetics Trial (Phase 1). ClinicalTrials.gov, 2015. ClinicalTrials.gov ↗ Vukojevic J, Milavić M, Perović D, et al. Pentadecapeptide BPC 157 and the central nervous system. Neural Regeneration Research, 2022. Full Text (PMC) ↗ Hsieh MJ, Liu HT, Wang CN, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Journal of Molecular Medicine, 2017. PubMed ↗ Osteogenic effect of a gastric pentadecapeptide, BPC-157, on the healing of segmental bone defect in rabbits. Journal of Orthopaedic Research, 1999. PubMed ↗ Lee E, Walker C, Ayadi B. Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. Alternative Therapies in Health and Medicine, 2025. PubMed ↗
References are provided for scientific background only. Atomix Research compounds are sold strictly for in-vitro laboratory and research use and are not intended to diagnose, treat, cure, or prevent any disease.
Important notes
Intended for research and laboratory use only. Must be handled by qualified research professionals. Store in a cool, dry place away from direct sunlight. Keep out of reach of children and unauthorized individuals. Follow all applicable local regulations regarding research compounds.